跳至主要内容
临床试验/JPRN-UMIN000008649
JPRN-UMIN000008649已完成未知

Efficacy of Mizoribine (MZR) treatment for gastrointestinal symptoms in kidney transplant recipients using mycophenolate mofetil (MMF). - Open-label, multicenter, randomized, controlled trial – - Mizoribine Convert Study

Tokyo Women Medical University, Dep. Urology0 个研究点目标入组 200 人开始时间: 2012年8月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.currently undergoing acute rejection 2.positive for DSA 3.serum creatinine level of less than 3mg/dL 4.a severe infection other than viral infection 5.white blood cell counts of less than 3,000/mm3 6.pregnant women and women suspected of being pregnant 7.aged 19 or younger 8.considered inappropriate by the doctor

研究者

发起方
Tokyo Women Medical University, Dep. Urology

相似试验